Reducing Residual Cardiovascular Risk in Patients With Atherogenic Dyslipidemia
Release Date: Jan 16, 2009    Expiration Date: Jan 15, 2010
Credits Available
1.0 Credit is available for Physicians
Faculty

Michael H. Davidson, MD
Clinical Professor and Director of Preventive Care
The University of Chicago Pritzker School of Medicine
Executive Medical Director, Radiant Research
Duke University Medical Center
Chicago, Illinois

Faculty Disclosure
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose any relevant affiliation or other financial relationship (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (2) with any commercial supporters of the activity. Conflict resolution must occur prior to the CME/CE activity. The ACHL also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a CME/CE activity.

The faculty members have provided the following disclosure information.

Michael H. Davidson, MD, has been a speakers bureau participant and a consultant for Abbott, AstraZeneca, Daiichi Sankyo, DiaDexus, Merck, Merck–Schering-Plough, Pfizer, Roche, and Takeda. He has been a speakers bureau participant for Oscient and a consultant for Sanofi-Aventis and Synarc. Dr. Davidson has received grant/research support from Abbott, AstraZeneca, Daiichi Sankyo, Merck, Merck–Schering-Plough, Pfizer, Roche, and Takeda. Dr. Davidson has been on advisory boards for Abbott, AstraZeneca, Atherogenics, Daiichi Sankyo, Kinemed, Merck, Merck–Schering-Plough, Oscient, Pfizer, PreEmptive Meds, Roche, Takeda, and Xinthria and on the board of directors for Angionen, Sonogene, and Professional Evaluation Inc.

Dean A. Bramlet, MD, has been a speakers bureau participant for Abbott, AstraZeneca,Merck, Sankyo, and Schering-Plough.

Sergio Fazio, MD, PhD, has been a speakers bureau participant and received honorarium from Abbot, Merck, and Schering-Plough.
Disclaimer
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Essential Areas and Elements, Policies, and Standards for Commercial Support as well as the ACPE Criteria for Quality and Interpretive Guidelines. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.

Participants are advised that one or more presentations in this CME/CE activity may contain references to unapproved or unlabeled uses of drugs or devices. Participants should note that the use of these agents outside current approved labeling is considered investigational and are advised to consult current prescribing information for these products.
Disclosure
The Academy for Continued Healthcare Learning staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Copyright © 2010 ACHL